Literature DB >> 9096651

Induction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesion.

C Rozzo1, V Chiesa, G Caridi, G Pagnan, M Ponzoni.   

Abstract

The survival, proliferation and differentiation of neuroblastoma (NB) cells are largely dependent on adhesion to extracellular matrix (ECM) proteins. Integrin occupancy seems to play a primary role. To elucidate the role of integrin heterodimers during neuronal cell death, we have analysed the changes in integrin expression in 2 human NB cell lines which represent different stages of neuronal maturation. Retinoic acid (RA) had different effects on the 2 NB cell lines: on LAN-5 cells it acted as a differentiation-promoting agent, while it had an anti-proliferative effect on GI-LI-N cells, driving them to apoptosis. Indeed, this occurrence was evidenced by the visualization of a "DNA ladder" on gel electrophoresis, by propidium iodide staining, and by DNA flow cytofluorimetric analysis. RA treatment rapidly and drastically decreased integrin expression and cell adhesion on GI-LI-N cells. These findings were also obtained by treating both NB cell lines with the apoptotic agent fenretinide. Furthermore, treatment of NB cells with anti-sense oligonucleotides to beta 1 integrin chain specifically induced chromatin condensation and nucleosomal DNA laddering. Moreover, blocking cell-matrix interactions by means of perturbing antibody against beta 1 subunit resulted in the induction of typical features of apoptotic cells. In conclusion, these findings indicate that abrogation of cell adhesion through down-modulation of integrin receptors plays a crucial role in the induction of neuroblastoma programmed cell death.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096651     DOI: 10.1002/(sici)1097-0215(19970317)70:6<688::aid-ijc11>3.0.co;2-6

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines.

Authors:  J S Damiano; A E Cress; L A Hazlehurst; A A Shtil; W S Dalton
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

2.  Regulation of keratin and integrin gene expression in cancer and drug resistance.

Authors:  N Daly; P Meleady; D Walsh; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

3.  Alkaline ceramidase 2 (ACER2) and its product dihydrosphingosine mediate the cytotoxicity of N-(4-hydroxyphenyl)retinamide in tumor cells.

Authors:  Zhehao Mao; Wei Sun; Ruijuan Xu; Sergei Novgorodov; Zdzislaw M Szulc; Jacek Bielawski; Lina M Obeid; Cungui Mao
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

4.  Sub-micromolar concentrations of retinoic acid induce morphological and functional neuronal phenotypes in SK-N-SH neuroblastoma cells.

Authors:  Emily Harasym; Nicole McAndrew; George Gomez
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-08-24       Impact factor: 2.416

5.  Alkaline ceramidase 2 regulates beta1 integrin maturation and cell adhesion.

Authors:  Wei Sun; Wei Hu; Ruijuan Xu; Junfei Jin; Zdzislaw M Szulc; Guofeng Zhang; Sehamuddin H Galadari; Lina M Obeid; Cungui Mao
Journal:  FASEB J       Date:  2008-10-22       Impact factor: 5.191

6.  MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma.

Authors:  Marco Lodrini; Ina Oehme; Christina Schroeder; Till Milde; Marie C Schier; Annette Kopp-Schneider; Johannes H Schulte; Matthias Fischer; Katleen De Preter; Filip Pattyn; Mirco Castoldi; Martina U Muckenthaler; Andreas E Kulozik; Frank Westermann; Olaf Witt; Hedwig E Deubzer
Journal:  Nucleic Acids Res       Date:  2013-04-26       Impact factor: 16.971

7.  Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line.

Authors:  V Appierto; E Cavadini; R Pergolizzi; L Cleris; R Lotan; S Canevari; F Formelli
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.